Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Flubendazole

Flubendazole

pharmaceutical raw materials
Flubendazole structure

Flubendazole 

structure
  • CAS No:

    31430-15-6

  • Formula:

    C16H12FN3O3

  • Chemical Name:

    Flubendazole

  • Synonyms:

    Carbamic acid,N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]-,methyl ester;2-Benzimidazolecarbamic acid,5-(p-fluorobenzoyl)-,methyl ester;Carbamic acid,[5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]-,methyl ester;Flubendazole;R 17899;Methyl (5-p-fluorobenzoyl-2-benzimidazolyl)carbamate;Flubenol;Fluvermal;R 17889;Flumoxane;Flumoxal;NSC 313680;Flubenvet

  • Categories:

    Active Pharmaceutical Ingredients  >  Antiparasitic Drugs

Description

White Solid


Flubendazole is a member of the class of mebendazole in which the benzoyl group is replaced by a p-fluorobenzoyl group. A broad-spectrum anthelmintic, it is used, particularly in veterinary medicine, for the treatment of nematodal infections. It has a role as an antinematodal drug and a teratogenic agent. It is a member of benzimidazoles, a carbamate ester, an organofluorine compound and an aromatic ketone.|Flubendazole is an anthelmintic that is used to treat worm infection in humans. It is available OTC in Europe.

Flubendazole Basic Attributes

313.28

313.28

250-624-4

R8M46911LR

313680

DTXSID8023058

P - Antiparasitic products, insecticides and repellents

29339900

Characteristics

84.1

2.9

white to pale yellow powder

1.3720 (estimate)

260 °C

1.685

LD50 in mice, rats, guinea pigs (mg/kg): >2560 orally (Thienpont)

177.36 Ų [M-H]-

Safety Information

2

22

44

DD6497500

P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, P501

H302

|Warning|H302 (14.29%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, and P501|Aggregated GHS information provided by 19 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)

flubendazole

Flubendazole Use and Manufacturing

Methods of Manufacturing

(2) when an R contains one or more R1, R2, or R4 substituents, the total number of substituents on that R is not more than 3; or a physiologically acceptable salt thereof; as well as a second active agent, which is a compound selected from the group consisting of albendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, thiabendazole, levamisole, morantel, ...General procedure: To a stirred mixture of each bendazole in base/solvent (100mM) were added 10 equiv of alcohols indicated in Scheme 1. The reaction proceeded at 90, 100, or 110C for 3h to o/n. For compounds 5 and 7, the reaction mixture was exposed to microwave irradiation for 5-15minat 60 or 70C. Workup: Once the reaction was complete, the solvent was removed under reduced pressure, diluted with four times the reaction volume of EtOAc and washed with water and brine. The organic layer was dried with Na2SO4 and concentrated in vacuo, followed by purification performed on automated flash chromatography system with the desired method commented below.The mixture of General procedure: To a stirred mixture of each bendazole in base/solvent (100mM) were added 10 equiv of alcohols indicated in Scheme 1. The reaction proceeded at 90, 100, or 110C for 3h to o/n. For compounds 5 and 7, the reaction mixture was exposed to microwave irradiation for 5-15minat 60 or 70C. Workup: Once the reaction was complete, the solvent was removed under reduced pressure, diluted with four times the reaction volume of EtOAc and washed with water and brine. The organic layer was dried with Na2SO4 and concentrated in vacuo, followed by purification performed on automated flash chromatography system with the desired method commented below.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.

Uses

An insectocidal agent.

Veterinary Drug -> ANTHELMINTHIC_AGENT; -> JECFA Functional Classes|Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

Veterinary Drug -> ANTHELMINTHIC_AGENT;

Computed Properties

Molecular Weight:313.28
XLogP3:2.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:4
Exact Mass:313.08626942
Monoisotopic Mass:313.08626942
Topological Polar Surface Area:84.1
Heavy Atom Count:23
Complexity:454
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Flubendazole

Latest News on Flubendazole

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.